Stories
Carlsberg India, TMC Transformers, Ujin Pharma Get SEBI Nod for IPOs
M
Moneycontrol•01-10-2026, 19:24
Carlsberg India, TMC Transformers, Ujin Pharma Get SEBI Nod for IPOs
- •Carlsberg India, TMC Transformers (India), Ujin Pharma, and Matangi Rubber have received regulatory clearance from SEBI to proceed with their proposed initial public offerings (IPOs).
- •SEBI issued observations on the companies' IPO proposals between September 28 and October 1, marking a crucial step in the IPO process.
- •Carlsberg India, the Indian subsidiary of the Danish brewing major, submitted confidential pre-filed draft papers with SEBI on July 1, utilizing a route that keeps commercially sensitive information private initially.
- •TMC Transformers (India) plans a Rs 550-crore fresh issue IPO to fund a new Extra High Voltage (EHV) transformer manufacturing facility in Halol, Gujarat, and meet working capital needs.
- •Ujin Pharma's proposed IPO includes a fresh issue of 1.18 crore equity shares and an offer-for-sale by promoters, with proceeds from the fresh issue to be invested in Altra Agro-Chem and Altra Pharma-Chem.
Key Questions Answered
Carlsberg India, TMC Transformers (India), Ujin Pharma, and Matangi Rubber received regulatory clearance from SEBI to proceed with their proposed initial public offerings.
TMC Transformers plans to use its IPO proceeds to fund capital expenditure for a greenfield Extra High Voltage transformer manufacturing facility in Gujarat, meet incremental working capital requirements, and for general corporate purposes.
Ujin Pharma’s proposed IPO comprises a fresh issue of 1.18 crore equity shares and an offer-for-sale of 72.82 lakh shares by promoters Jinesh Rasiklal Sheth and Umang Ketan Mehta.
